Ritlecitinib for alopecia areata
Ritlecitinib is in clinical development for the treatment of patients with alopecia areata (AA). AA is a disease that develops when the body attacks its own hair follicles (where the hair grows from), which can cause hair loss as small round patches of baldness anywhere on the body. Most commonly, this occurs on the scalp …
Granexin Gel for Diabetic Foot Ulcers
When blood sugar levels are high or fluctuate regularly, as in people with diabetes, skin that would normally heal may not properly repair itself because of nerve damage. As a result, even a mild injury can start a foot ulcer. Granexin gel contains the peptide ACT1, which possesses potential anti-inflammatory and regenerative properties when administered topically to diabetic foot ulcers. If licensed, granexin gel may offer an additional therapy option for diabetic foot ulcers which are a particularly difficult-to-treat chronic wound type.
Visualase™ system for minimally invasive soft tissue ablation
The Visualase™ system, developed by Medtronic plc, is indicated to necrotize or coagulate soft tissue through interstitial thermal therapy under MRI guidance. The Visualase™ system comprises a cooled laser applicator and a working station containing a peristaltic pump for circulating coolant (saline) through the applicator, a diode laser energy source and a computer with MRI analysis software …
ivWatch Model 400 patient monitor for continuous monitoring of IV sites
The ivWatch Model 400 patient monitor helps doctors and nurses find out whether a drip in the vein is leaking into the surrounding tissue. If this happens, it can cause pain, infection, tissue damage and loss of limb. The ivWatch system contains a patient monitor, a light, and a single-use container that secures the light …
SensiumVitals® vital signs monitoring patch
SensiumVitals® is a wireless, wearable, disposable patch, which monitors vital signs of patients to provide early identification of physical deterioration and opportunities for early intervention.
OrganOx® metra™ for liver preservation during transplantation
The OrganOx® metra™ is a portable device in development by OrganOx Limited that is intended to be used during liver transplantation to preserve and maintain the donated liver for up to 24 hours between the point of retrieval and transplantation.